HF
ABMD

HRT Financial’s Abiomed Inc ABMD Stock Holding History

HRT Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,600
Closed -$614K – 1503
2019
Q4 		$614K Buy
+3,600
New +$667K 0.03% 468

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRT Financial's ABMD Position: Q4 2021 in Review

HRT Financial sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 27,808 shares — an estimated $9.05M sold.

HRT Financial first reported a position in ABMD in Q1 2019 and held it in 4 quarters. The position peaked at $9.05M in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • HRT Financial reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 27,808 Abiomed Inc shares in Q4 2021, an estimated $9.05M.
  • HRT Financial first reported a position in Abiomed Inc in Q1 2019 and held it in 4 quarters.
  • HRT Financial's Abiomed Inc position peaked at $9.05M in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.